Skip to main content

Table 7 Most common and serious Adverse events During TMZ/WBRT treatment according to Common Toxicity Criteria extended by National Cancer Institute, (NCI CTC) in the 59 enrolled patients.

From: Concomitant treatment of brain metastasis with Whole Brain Radiotherapy [WBRT] and Temozolomide [TMZ] is active and improves Quality of Life

 

Grade 2

 

Grade 3

 

Grade 4

 

Toxicity

No. pts

%

No. pts

%

No. pts

%

Neutropenia

15

25

9

15

-

-

Thrombocytopenia

4

7

2

3

1

1

Anemia

7

12

8

13

-

-

Alopecia

2

3

-

-

-

-

Vomiting

6

10

2

3

  

hand and foot syndrome

2

3

-

-

-

-

Headache

5

8

1

1

-

-

Nausea

5

8

2

3

-

-

Tremor

4

7

2

3

-

-

Nerosensory

3

5

-

-

-

-

Fatigue

7

12

2

3

-

-

Rash

8

13

3

5

-

-